Sevin Rosen Funds appeared to be the VC, which was created in 1981. The company was established in North America in United States. The main office of represented VC is situated in the Dallas.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Sevin Rosen Funds, startups are often financed by Menlo Ventures, CenterPoint Venture Partners, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Oak Investment Partners, Intel Capital, H.I.G. Capital. In the next rounds fund is usually obtained by Rho Ventures, New Enterprise Associates, Rho Capital Partners.
Among the most popular fund investment industries, there are Enterprise Software, Telecommunications. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline NetLogic Microsystems, Splunk, Xtera The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little.
The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The typical startup value when the investment from Sevin Rosen Funds is 50-100 millions dollars. The top amount of exits for fund were in 2009. Comparing to the other companies, this Sevin Rosen Funds performs on 1 percentage points less the average number of lead investments. The important activity for fund was in 2000. The fund is constantly included in 2-6 deals per year.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Netsocket | $9M | 02 Apr 2013 | Plano, Texas, United States | ||
$10M | 20 Apr 2011 | Denver, Colorado, United States | |||
AirWalk Communications | $10M | 08 Feb 2011 | Richardson, Texas, United States | ||
Vidyo | $11M | 19 Jan 2011 | New Jersey, United States | ||
Vidyo | $25M | 01 Apr 2010 | New Jersey, United States | ||
BioBehavioral Diagnostics | $10M | 17 Mar 2010 | Massachusetts, United States | ||
Metabolon | $6M | 07 Dec 2009 | Durham, North Carolina, United States | ||
Metabolon | $6M | 27 Oct 2009 | Durham, North Carolina, United States | ||
Limerick BioPharma | $15M | 15 Jul 2009 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Netsocket | $9M | 02 Apr 2013 | Plano, Texas, United States | ||
$10M | 20 Apr 2011 | Denver, Colorado, United States | |||
AirWalk Communications | $10M | 08 Feb 2011 | Richardson, Texas, United States | ||
Vidyo | $11M | 19 Jan 2011 | New Jersey, United States | ||
Vidyo | $25M | 01 Apr 2010 | New Jersey, United States | ||
BioBehavioral Diagnostics | $10M | 17 Mar 2010 | Massachusetts, United States | ||
Metabolon | $6M | 07 Dec 2009 | Durham, North Carolina, United States | ||
Metabolon | $6M | 27 Oct 2009 | Durham, North Carolina, United States | ||
Limerick BioPharma | $15M | 15 Jul 2009 | South San Francisco, California, United States |